The energy used to drive many chemical reactions in muscle is derived from the hydrolysis of energy-rich phosphate compounds, such as Adenosine-5'-triphosphate (ATP). However, as they are effectors of many enzymes, the concentration of adenine nucleotides is carefully regulated and they may not be used as a major energy store in muscle. Instead, in muscle, large amounts of phosphate are stored as phosphocreatine, which has approximately the same free energy of hydrolysis as ATP. The highest levels of phosphocreatine are found in skeletal muscle and in the heart, where it is used as a rapidly available energy store for bursts of activity [1] . When phosphocreatine is hydrolysed to creatine and phosphate, part of the creatine is further metabolized by an irreversible reaction to creatinine, which is formed at a constant rate that is proportional to the creatine-phosphocreatine pool and hence the muscle mass [1, 2] . As almost all creatinine is excreted in the urine mainly through glomerular filtration, it has, for decades, been used as a surrogate marker of glomerular filtration rate (GFR) [3, 4] . The determination of serum or plasma creatinine has been one cornerstone of diagnosis, as well as follow-up of chronic kidney disease (CKD). Recently, several different creatinine-based equations for the estimation of GFR have been validated and widely adopted for the staging of CKD as well as for follow-up, and planning of dialysis initiation [5] .
However, the use of creatinine for estimation of the GFR is limitated by differences in creatinine generation (due to differences in muscle mass and meat intake), different assays and lack of standardization of the creatinine methods [6] and interaction with drugs and metabolites. In addition, with decreasing renal function, the tubular excretion and the degradation of creatinine by bacteria in the gut increase and become a significant proportion in relation to the glomerular filtration [1, 4, 7] .
In acute kidney injury (AKI), creatinine is useful to follow the progress of AKI, but since the patient is not in a steady state, it is a less valid marker to estimate GFR. Also, with a very low renal function, inter-patient differences in the plasma creatinine level will mainly be due to differences in the creatinine generation rate. In the present study by Wilson et al. [8] , the creatinine generation rate in AKI patients treated with continuous renal replacement therapy was investigated. The study comprised 103 anuric patients who received stable continuous veno-venous haemodialysis and who were in a steady state in regard to plasma creatinine levels. This is a sagacious study design, which enabled the authors to calculate the creatinine generation rate from the dialysate effluent volume and effluent creatinine concentration (in the prospective cohort of the study) and plasma creatinine levels (in the retrospective cohort). It was found that the creatinine generation rate was markedly lower in their patients, compared to what was expected from different equations derived to assess eGFR. Moreover, a low creatinine generation rate was a strong predictor of outcome, which turned out to be a better predictor of in-hospital mortality compared with a variety of other factors including the SOFA score [8] .
It is not completely clear why the creatinine generation rate is so markedly reduced during AKI, or why it is such a strong predictor of outcome. Evidently, there is no meat intake in these severely sick patients with the majority on mechanical ventilation. The long hospital stay, catabolic stimuli and inactivity will also inevitably result in a marked decrease in their muscle mass. It has been suggested that catabolism of creatinine by the intestinal flora may be responsible for as much as 30% of the total catabolism [7] , and it is possible that this amount would change in patients with AKI. However, it is more likely that this amount would decrease rather than increase in severely diseased intensive care unit (ICU) patients such as those in the present study [8] . In particular, in ICU patients with intestinal or liver disease the intestinal flora may be affected in such a way that it results in decreased creatinine degradation, which would increase the estimated creatinine generation rate and result in opposite changes than reported by the authors [8] . Furthermore, as the authors found no significant correlations between the creatinine generation rate and gender, race or age (classic predictors of the creatinine generation rate used in almost all eGFR equations) there seemed to be no relationships between the creatinine generation rate and their predisease muscle mass. It is possible that the results to some extent are confounded by variability of the pharmacological treatment, and that the most sick patients with the worst prognosis more frequently were given high doses of steroids. This might have resulted in an increased muscle catabolism through increased activation of the ubiquitin proteasome proteolytic pathway [9, 10] . In ICU patients, steroid therapy has been reported to be associated with low myosin/actin ratio, worsened athropy-related gene expression. In addition, a reduction in myofibre size when corticosteroid treatment was prolonged for >7 days was reported [11] . It is possible that the poor prognosis in patients with decreased creatinine generation rate at least to some extent was due to more frequent use of steroids in this group (and perhaps also other drugs with catabolic effects such as neuromuscular blockers [12] ). However, in our opinion, the most likely explanation for the present findings is other mechanisms. A clue is that the authors found a decrease in the creatinine generation rate with every day spent in hospital as well as in patients with an oncological diagnosis. Cancer patients may have severe sarcopenia, which to some extent may explain the latter finding, but it is unlikely that only a decrease in muscle mass should explain the relation to hospital stay. In such cases, there should also be relationships to age, race and gender. Thus, other mechanisms must be involved.
Patients with long-standing multi-organ failure often develop a hypometabolic state, which may in part be an adaptive process to protect cell survival. A decreased metabolic rate and mitochondrial activity appear to play a key role in the processes underlying this condition and reduced production of energy-rich phosphates will compromise normal metabolic functioning. It is also likely that the results of the present study are due to depletion of tissue stores of phosphocreatine and perhaps also other energy-rich phosphates. With severe disease, the stores of phosphocreatine are markedly depleted in several tissues, including muscle and heart [1] . This effect is likely potentiated by inflammation. Although the authors did not measure inflammatory markers in their study, a correlation between the negative-phase reactant serum albumin and the creatinine generation rate was found. Moreover, severe infection has been found to markedly increase creatinine excretion in rats [13] , likely resulting in more rapid phosphocreatine depletion. The reduction of phosphocreatine stores will result in a decreased creatinine generation rate, as demonstrated by Wilson et al. [8] , as well as in hampered function of several tissues, in particular, skeletal muscle and heart. The depletion of energy stores will be particularly harmful in the heart in situations of decreased oxygen delivery, which often occurs in ICU patients. As the production of energy-rich phosphates in the cardiomyocytes is almost exclusively dependent on mitochondrial oxidative phosphorylation, production of energy-rich phosphates will be challenged when oxygen delivery falls below a critical limit. It has been demonstrated that at conditions of low-oxygen stress in cardiomyocytes, when phosphocreatine levels have decreased markedly, the ATP levels will decrease, resulting in severely impaired cardiac contractibility [1] . It is likely that this mechanism, and similar mechanisms in other tissues, may explain the strong impact of creatinine generation rate on the outcome in the present study. It is worth mentioning that phosphocreatine stores are important also for functions of other organs such as the brain. It is possible that this has implications also for critically ill patients without AKI, but this of course needs separate studies. It is possible to test these hypotheses by measuring the relation between energy stores in muscle tissue and the creatinine generation rate in different critically ill patient groups.
For the clinician, several important messages are given in the present study [8] . First, creatinine generation is easy to calculate and should be widely adopted for better assessment of the prognosis of patients with AKI in the ICU. Also, as the creatinine generation rate is markedly reduced, commonly used equations for eGFR should not be applied in AKI patients, neither at the debut of AKI nor during its recovery. The common equations for eGFR will markedly overestimate GFR and may potentially result in overdosing of drugs with renal excretion and risk of side effects. It is therefore crucial to monitor plasma concentrations of potentially toxic drugs with renal elimination in patients with AKI. In summary, the present study raises important issues in regard to the pathogenesis behind the high mortality in critically ill AKI patients, the estimation of GFR as well as the clinical management of these patients. 
